NCT00002642 - SWOG-9416: Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Stage III Non-small Cell Lung Cancer | Biotech Hunter

Enrollment

116

Participants

Timeline

Start Date

April 30, 1995

Primary Completion Date

January 31, 2001

Study Completion Date

July 31, 2004

Conditions

Lung Cancer

Interventions

DRUG

cisplatin

50 mg/m2, IV Days 1 and 8, two 28 day cycles prior to surgery and two 28 day cycles after surgery

DRUG

etoposide

50 mg/m2, IV Days 1-5, two 28 day cycles prior to surgery and two 28 day cycles after surgery

PROCEDURE

conventional surgery

surgery some time between weeks 9 and 12

RADIATION

low-LET cobalt-60 gamma ray therapy

180 cGy per day, Days 1-5, weekly for 5 weeks

Trial Locations (1)

Vanderbilt Cancer Center, Nashville